These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31476163)

  • 1. Gait Disorders in Alzheimer's Disease and Other Dementias: There is Something in the Way You Walk.
    Montero-Odasso M; Perry G
    J Alzheimers Dis; 2019; 71(s1):S1-S4. PubMed ID: 31476163
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive dementia and gait disorder in a 78 year old woman.
    Tagliati M; Perl DP; Drayer B; Olanow CW
    J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):526-31. PubMed ID: 10727496
    [No Abstract]   [Full Text] [Related]  

  • 3. [Organization of out-patient psychiatric care in dementia and cognitive impairment. Part I: Memory clinics and Alzheimer's disease centers].
    Mikhaylova NM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):111-119. PubMed ID: 28745681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild cognitive impairment.
    Gordon C; Martin DJ
    Expert Rev Neurother; 2013 Nov; 13(11):1247-61. PubMed ID: 24175723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Impairment in Older Adults: Epidemiology, Diagnosis, and Treatment.
    Pérez Palmer N; Trejo Ortega B; Joshi P
    Psychiatr Clin North Am; 2022 Dec; 45(4):639-661. PubMed ID: 36396270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cognition, physical performance, and gait in the context of mild cognitive impairment and dementia.
    Bruce-Keller AJ; Brouillette RM; Tudor-Locke C; Foil HC; Gahan WP; Correa J; Nye DM; Keller JN
    J Am Geriatr Soc; 2012 Jan; 60(1):176-7. PubMed ID: 22239310
    [No Abstract]   [Full Text] [Related]  

  • 7. Gait phenotype from mild cognitive impairment to moderate dementia: results from the GOOD initiative.
    Allali G; Annweiler C; Blumen HM; Callisaya ML; De Cock AM; Kressig RW; Srikanth V; Steinmetz JP; Verghese J; Beauchet O
    Eur J Neurol; 2016 Mar; 23(3):527-41. PubMed ID: 26662508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating dementia disease subtypes with gait analysis: feasibility of wearable sensors?
    Mc Ardle R; Del Din S; Galna B; Thomas A; Rochester L
    Gait Posture; 2020 Feb; 76():372-376. PubMed ID: 31901765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beyond Cognitive Impairment: Neuropsychiatric Symptoms in Neurodegenerative Dementias].
    Ahunca Velásquez LF
    Rev Colomb Psiquiatr; 2017 Oct; 46 Suppl 1():51-58. PubMed ID: 29037339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to the forgetful patient.
    Yoon PS; Ooi CH; How CH
    Singapore Med J; 2018 Mar; 59(3):121-125. PubMed ID: 29568856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease, dementia, mild cognitive impairment and the menopause: a 'window of opportunity'?
    Davey DA
    Womens Health (Lond); 2013 May; 9(3):279-90. PubMed ID: 23638783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of transcranial magnetic stimulation in the diagnosis and in the management of dementia.
    Cantone M; Di Pino G; Capone F; Piombo M; Chiarello D; Cheeran B; Pennisi G; Di Lazzaro V
    Clin Neurophysiol; 2014 Aug; 125(8):1509-32. PubMed ID: 24840904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are Cognitive Subtypes Associated with Dual-Task Gait Performance in a Clinical Setting?
    Cullen S; Borrie M; Carroll S; Sarquis-Adamson Y; Pieruccini-Faria F; McKay S; Montero-Odasso M
    J Alzheimers Dis; 2019; 71(s1):S57-S64. PubMed ID: 31322559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive intervention for early stage dementia: Research and techniques.
    DenBoer JW
    Appl Neuropsychol Adult; 2018; 25(6):562-571. PubMed ID: 28880690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Functional and Cognitive Impairment in Institutionalized Individuals with Movement Disorders.
    Cebrián PD; Cauli O
    Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1022-1031. PubMed ID: 30854981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep and Dementia.
    Shenker JI; Singh G
    Mo Med; 2017; 114(4):311-315. PubMed ID: 30228618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular Risk Factors and Lesions of Vascular Nature in Magnetic Resonance as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment.
    Romero-Sevilla R; Casado-Naranjo I; Portilla-Cuenca JC; Duque-de San Juan B; Fuentes JM; Lopez-Espuela F
    Curr Alzheimer Res; 2018; 15(7):671-678. PubMed ID: 29357793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new national survey of centers for cognitive disorders and dementias in Italy.
    Bacigalupo I; Giaquinto F; Salvi E; Carnevale G; Vaccaro R; Matascioli F; Remoli G; Vanacore N; Lorenzini P;
    Neurol Sci; 2024 Feb; 45(2):525-538. PubMed ID: 37592124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactory testing in consecutive patients referred with suspected dementia.
    Christensen IT; Larsson EM; Holm IE; Nielsen OBF; Andersen S
    BMC Geriatr; 2017 Jun; 17(1):129. PubMed ID: 28633628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular cognitive impairment.
    Nat Rev Dis Primers; 2018 Feb; 4():18004. PubMed ID: 29446768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.